These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 26752703)

  • 21. Urine as a biological modality for colorectal cancer detection.
    Chandrapalan S; Arasaradnam RP
    Expert Rev Mol Diagn; 2020 May; 20(5):489-496. PubMed ID: 32130868
    [No Abstract]   [Full Text] [Related]  

  • 22. Screening for volatile biomarkers of colorectal cancer by analyzing breath and fecal samples using thermal desorption combined with GC-MS (TD-GC-MS).
    Śmiełowska M; Ligor T; Kupczyk W; Szeliga J; Jackowski M; Buszewski B
    J Breath Res; 2023 Jul; 17(4):. PubMed ID: 37406626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sex and Smoking Status Effects on the Early Detection of Early Lung Cancer in High-Risk Smokers Using an Electronic Nose.
    McWilliams A; Beigi P; Srinidhi A; Lam S; MacAulay CE
    IEEE Trans Biomed Eng; 2015 Aug; 62(8):2044-54. PubMed ID: 25775482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of colorectal cancer (CRC) by urinary volatile organic compound analysis.
    Arasaradnam RP; McFarlane MJ; Ryan-Fisher C; Westenbrink E; Hodges P; Thomas MG; Chambers S; O'Connell N; Bailey C; Harmston C; Nwokolo CU; Bardhan KD; Covington JA
    PLoS One; 2014; 9(9):e108750. PubMed ID: 25268885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic intestinal Mycobacteria infection: discrimination via VOC analysis in exhaled breath and headspace of feces using differential ion mobility spectrometry.
    Purkhart R; Köhler H; Liebler-Tenorio E; Meyer M; Becher G; Kikowatz A; Reinhold P
    J Breath Res; 2011 Jun; 5(2):027103. PubMed ID: 21512209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid recognition of volatile organic compounds with colorimetric sensor arrays for lung cancer screening.
    Zhong X; Li D; Du W; Yan M; Wang Y; Huo D; Hou C
    Anal Bioanal Chem; 2018 Jun; 410(16):3671-3681. PubMed ID: 29654337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blinded Validation of Breath Biomarkers of Lung Cancer, a Potential Ancillary to Chest CT Screening.
    Phillips M; Bauer TL; Cataneo RN; Lebauer C; Mundada M; Pass HI; Ramakrishna N; Rom WN; Vallières E
    PLoS One; 2015; 10(12):e0142484. PubMed ID: 26698306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Noninvasive detection of colorectal cancer by analysis of exhaled breath.
    Wang C; Ke C; Wang X; Chi C; Guo L; Luo S; Guo Z; Xu G; Zhang F; Li E
    Anal Bioanal Chem; 2014 Jul; 406(19):4757-63. PubMed ID: 24820062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-invasive cancer detection using volatile biomarkers: Is urine superior to breath?
    Becker R
    Med Hypotheses; 2020 Oct; 143():110060. PubMed ID: 32683218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of the PEN3 e-nose in the screening of colorectal cancer and polyps.
    Altomare DF; Porcelli F; Picciariello A; Pinto M; Di Lena M; Caputi Iambrenghi O; Ugenti I; Guglielmi A; Vincenti L; De Gennaro G
    Tech Coloproctol; 2016 Jun; 20(6):405-409. PubMed ID: 27000856
    [No Abstract]   [Full Text] [Related]  

  • 31. Feasibility of volatile organic compound in breath analysis in the follow-up of colorectal cancer: A pilot study.
    Steenhuis EGM; Schoenaker IJH; de Groot JWB; Fiebrich HB; de Graaf JC; Brohet RM; van Dijk JD; van Westreenen HL; Siersema PD; de Vos Tot Nederveen Cappel WH
    Eur J Surg Oncol; 2020 Nov; 46(11):2068-2073. PubMed ID: 32778485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Review of recent developments in determining volatile organic compounds in exhaled breath as biomarkers for lung cancer diagnosis.
    Zhou J; Huang ZA; Kumar U; Chen DDY
    Anal Chim Acta; 2017 Dec; 996():1-9. PubMed ID: 29137702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential role of volatile organic compound breath testing in the Australasian colorectal cancer pathway.
    Gower H; Danielson K; Dennett APE; Deere J
    ANZ J Surg; 2023 May; 93(5):1159-1161. PubMed ID: 36629356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic performance of volatile organic compounds analysis and electronic noses for detecting colorectal cancer: a systematic review and meta-analysis.
    Wang Q; Fang Y; Tan S; Li Z; Zheng R; Ren Y; Jiang Y; Huang X
    Front Oncol; 2024; 14():1397259. PubMed ID: 38817891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A volatile biomarker in breath predicts lung cancer and pulmonary nodules.
    Phillips M; Bauer TL; Pass HI
    J Breath Res; 2019 Jun; 13(3):036013. PubMed ID: 31085817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The scent of colorectal cancer: detection by volatile organic compound analysis.
    de Boer NK; de Meij TG; Oort FA; Ben Larbi I; Mulder CJ; van Bodegraven AA; van der Schee MP
    Clin Gastroenterol Hepatol; 2014 Jul; 12(7):1085-9. PubMed ID: 24823289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of lifestyle factors on fecal volatile organic compound composition as measured by an electronic nose.
    Bosch S; Lemmen JP; Menezes R; van der Hulst R; Kuijvenhoven J; Stokkers PC; de Meij TG; de Boer NK
    J Breath Res; 2019 Jun; 13(4):046001. PubMed ID: 31170704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breathprinting and Early Diagnosis of Lung Cancer.
    Rocco G; Pennazza G; Santonico M; Longo F; Rocco R; Crucitti P; Antonelli Incalzi R
    J Thorac Oncol; 2018 Jul; 13(7):883-894. PubMed ID: 29526822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosing gastrointestinal illnesses using fecal headspace volatile organic compounds.
    Chan DK; Leggett CL; Wang KK
    World J Gastroenterol; 2016 Jan; 22(4):1639-49. PubMed ID: 26819529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exhaled VOC detection in lung cancer screening: a comprehensive meta-analysis.
    Fan X; Zhong R; Liang H; Zhong Q; Huang H; He J; Chen Y; Wang Z; Xie S; Jiang Y; Lin Y; Chen S; Liang W; He J
    BMC Cancer; 2024 Jun; 24(1):775. PubMed ID: 38937687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.